Moreover, the CXCR4–CXCL12 pathway contributes to cell proliferation and angiogenesis, suggesting it may further enhance CTCL progression by augmenting tumor-cell growth and TME vascularization [73]. The gene discussed is CXCL12; the disease is neoplasm.